CUL3 and intrahepatic cholangiocarcinoma: To identify additional drivers that accelerate ICC formation, we previously performed CRISPR/Cas9-mediated genome-wide screening targeting 20,611 genes in SPC mice and identified Cul3 as a tumor suppressor, whose disruption accelerated ICC formation by inducing inflammation in the liver [9].